Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Dreger, Peter  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
Kyriakou, C., Boumendil, A., Finel, H., Finel, H., Andersen, N.Smedegaard, Blaise, D., Chevallier, P., Browne, P., Malladi, R., Niederwieser, D., et al. (2018). The impact of advanced patient age on mortality after allogeneic hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma: A retrospective study by the EBMT Lymphoma Working Party.Biol Blood Marrow Transplant.
Scheffold, A., Jebaraj, B.Michael Ch, Jaramillo, S., Tausch, E., Steinbrecher, D., Hahn, M., Böttcher, S., Ritgen, M., Bunjes, D., Zeis, M., et al. (2016). Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial.Br J Haematol.
Radujkovic, A., Luft, T., Dreger, P., Ho, A.D., W Zeller, J., Fruehauf, S., and Topaly, J. (2014). In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemia.Cancer Chemother Pharmacol.
Bazarbachi, A., Boumendil, A., Finel, H., Castagna, L., Dominietto, A., Blaise, D., Diez-Martin, J.L., Tischer, J., Gulbas, Z., Wallet, H.L., et al. (2019). Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study.Br J Haematol.
Radujkovic, A., Kordelas, L., Dai, H., Schult, D., Majer-Lauterbach, J., Beelen, D., Müller-Tidow, C., Dreger, P., and Luft, T. (2019). Interleukin-18 and outcome after allogeneic stem cell transplantation: A retrospective cohort study.Ebiomedicine.